4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-20-063600
Options or other derivatives
- Chief Legal & Adm. Officer acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…